Literature DB >> 14675587

Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease.

Kyung-Han Lee1, Hong-Joo Jang, Young-Hwan Kim, Eun Jung Lee, Yearn Seong Choe, Yong Choi, Mun Gyu Lee, Sang Hoon Lee, Byung-Tae Kim.   

Abstract

We investigated the prognostic value of cardiac autonomic neuropathy (CAN) in relation to perfusion defects in 146 diabetic patients with suspected coronary artery disease. Perfusion defects and CAN were significant univariate predictors of death (p=0.05 and p<0.001, respectively) and cardiac events (p<0.001 and p<0.002, respectively). However, CAN remained a significant predictor of death and cardiac events after adjustment for perfusion defects (both p<0.02), and provided prognostic information incremental to that offered by perfusion defects alone (p<0.003 and p<0.006, respectively).

Entities:  

Mesh:

Year:  2003        PMID: 14675587     DOI: 10.1016/j.amjcard.2003.08.060

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Cardiovascular autonomic neuropathy: diagnosis and management.

Authors:  Aaron I Vinik; Tomris Erbas
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  I-123 metaiodobenzylguanidine imaging in non-insulin-dependent diabetic patients with normal myocardial perfusion scans: new insights into their increased cardiac morbidity and mortality rates.

Authors:  Nauman Mushtaq; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

3.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

4.  Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms.

Authors:  Jacobijne J Wiersma; Hein J Verberne; Mieke D Trip; Wik L ten Holt; Berthe L F van Eck-Smit; Jan J Piek; Jan G P Tijssen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-21       Impact factor: 10.057

5.  Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review.

Authors:  Sandeep Chopra; Soumia Peter
Journal:  Indian J Endocrinol Metab       Date:  2012-01

Review 6.  Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis.

Authors:  Mahin Chowdhury; Sarah Nevitt; Aikaterini Eleftheriadou; Prathap Kanagala; Hani Esa; Daniel J Cuthbertson; Abd Tahrani; Uazman Alam
Journal:  BMJ Open Diabetes Res Care       Date:  2021-12

7.  Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea.

Authors:  Sol Jae Lee; Su Jin Jeong; Yu Chang Lee; Yong Hoon Lee; Jung Eun Lee; Chong Hwa Kim; Kyung Wan Min; Bong Yun Cha
Journal:  Diabetes Metab J       Date:  2017-08       Impact factor: 5.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.